Provided by Tiger Fintech (Singapore) Pte. Ltd.

Praxis Precision Medicines, Inc.

35.98
+0.64001.81%
Post-market: 35.980.00000.00%16:30 EDT
Volume:501.93K
Turnover:18.18M
Market Cap:725.47M
PE:-3.52
High:37.09
Open:35.79
Low:35.53
Close:35.34
Loading ...

Piper Sandler Keeps Their Buy Rating on Praxis Precision Medicines (PRAX)

TIPRANKS
·
16 Jan

Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities

THOMSON REUTERS
·
13 Jan

Press Release: Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities

Dow Jones
·
13 Jan

Praxis Precision Medicines (PRAX) Receives a Buy from Piper Sandler

TIPRANKS
·
10 Jan

Praxis Precision Medicines Files for Mixed Shelf, $250 Million Common Stock Sale

MT Newswires Live
·
24 Dec 2024

BRIEF-Praxis Precision Medicines Inc Files For Mixed Shelf

Reuters
·
24 Dec 2024

Praxis Precision files automatic mixed securities shelf

TIPRANKS
·
24 Dec 2024

Praxis Precision Medicines : Sales Agreement Prospectus Covering Offering up to $250 Mln of Common Stock That May Be Issued From Time to Time

THOMSON REUTERS
·
24 Dec 2024

Praxis Precision Medicines Inc Files for Mixed Shelf- SEC Filing

THOMSON REUTERS
·
24 Dec 2024

Praxis Says FDA Grants Rare Pediatric Disease Designation to Relutrigine to Treat Dravet Syndrome

MT Newswires Live
·
18 Dec 2024

BRIEF-Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted For Relutrigine In Dravet Syndrome

Reuters
·
18 Dec 2024

Praxis Precision Medicines Inc - to Initiate All-Dee Trial Including Dravet Syndrome in 1H2025

THOMSON REUTERS
·
18 Dec 2024

Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome

THOMSON REUTERS
·
18 Dec 2024

Here's Why We're Not Too Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Situation

Simply Wall St.
·
13 Dec 2024

Praxis Precision Med Price Target Maintained With a $120.00/Share by HC Wainwright & Co.

Dow Jones
·
12 Dec 2024

Promising Pipeline and Strategic Developments Position Praxis Precision Medicines for Market Expansion

TIPRANKS
·
12 Dec 2024

Praxis Precision Medicines Inc : Jefferies Raises Target Price to $305 From $144

THOMSON REUTERS
·
11 Dec 2024

GeneDx expands access to exome testing for pediatric epilepsy patients

TIPRANKS
·
05 Dec 2024

Praxis Precision to present preclinical, clinical data from epilepsy programs

TIPRANKS
·
26 Nov 2024

Praxis Precision Medicines Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
08 Nov 2024